Dias B, Lamarca A, Machado D, Kloh V, de Carvalho F, Vasconcelos A
Anim Microbiome. 2025; 7(1):20.
PMID: 40033444
PMC: 11874851.
DOI: 10.1186/s42523-025-00379-y.
Arulvasan W, Greenwood J, Ball M, Chou H, Coplowe S, Birch O
Metabolomics. 2025; 21(1):17.
PMID: 39832034
PMC: 11747010.
DOI: 10.1007/s11306-024-02218-8.
Bortoluzzi C, Ghanbari M, Gonzales J, Bohorquez J, Paredes R, Mauri Y
Poult Sci. 2025; 104(2):104664.
PMID: 39805250
PMC: 11770487.
DOI: 10.1016/j.psj.2024.104664.
Luangphiphat W, Prombutara P, Jamjuree P, Chantarangkul C, Vitheejongjaroen P, Muennarong C
PLoS One. 2025; 20(1):e0317202.
PMID: 39792908
PMC: 11723615.
DOI: 10.1371/journal.pone.0317202.
Ng C, Zhong L, Ng H, Goh K, Zhao Y
Nutrients. 2024; 16(22).
PMID: 39599721
PMC: 11597546.
DOI: 10.3390/nu16223935.
Ex vivo and miniaturized in vitro to study microbiota-gut-brain axis.
Yata V
3 Biotech. 2024; 14(11):280.
PMID: 39464520
PMC: 11502650.
DOI: 10.1007/s13205-024-04126-z.
Gut microbiota: Implications in pathogenesis and therapy to cardiovascular disease (Review).
Lin L, Xiang S, Chen Y, Liu Y, Shen D, Yu X
Exp Ther Med. 2024; 28(5):427.
PMID: 39301250
PMC: 11411594.
DOI: 10.3892/etm.2024.12716.
Effects of tetragonum tablets and Jin Gui Ren Qi Pill on intestinal flora and metabolism in patients with diabetic kidney disease.
Zhang C, Yue D, Wang D, Wu F
Front Pharmacol. 2024; 15:1346168.
PMID: 39139646
PMC: 11319841.
DOI: 10.3389/fphar.2024.1346168.
Adolescent gut microbiome imbalance and its association with immune response in inflammatory bowel diseases and obesity.
Joo M, Nam S
BMC Microbiol. 2024; 24(1):268.
PMID: 39030520
PMC: 11264842.
DOI: 10.1186/s12866-024-03425-y.
From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson's Disease Treatment?.
Vilela C, Araujo B, Soares-Guedes C, Caridade-Silva R, Martins-Macedo J, Teixeira C
Cells. 2024; 13(9.
PMID: 38727306
PMC: 11083070.
DOI: 10.3390/cells13090770.
Exploring of gut microbiota features in dyslipidemia and chronic coronary syndrome patients undergoing coronary angiography.
Luangphiphat W, Prombutara P, Muangsillapasart V, Sukitpunyaroj D, Eeckhout E, Taweechotipatr M
Front Microbiol. 2024; 15:1384146.
PMID: 38646625
PMC: 11026706.
DOI: 10.3389/fmicb.2024.1384146.
Gut microbiome diversity and function during hibernation and spring emergence in an aquatic frog.
Lee J, Park J, Do Y
PLoS One. 2024; 19(2):e0298245.
PMID: 38363754
PMC: 10871480.
DOI: 10.1371/journal.pone.0298245.
The Networked Interaction between Probiotics and Intestine in Health and Disease: A Promising Success Story.
Skoufou M, Tsigalou C, Vradelis S, Bezirtzoglou E
Microorganisms. 2024; 12(1).
PMID: 38258020
PMC: 10818559.
DOI: 10.3390/microorganisms12010194.
Metabolomic Profiling of Obese Patients with Altered Intestinal Permeability Undergoing a Very Low-Calorie Ketogenic Diet.
Calabrese F, Celano G, Riezzo G, DAttoma B, Ignazzi A, Di Chito M
Nutrients. 2023; 15(24).
PMID: 38140285
PMC: 10745951.
DOI: 10.3390/nu15245026.
Tadpole growth rates and gut bacterial community: Dominance of developmental stages over temperature variations.
Park J, Park W, Do Y
PLoS One. 2023; 18(10):e0292521.
PMID: 37796877
PMC: 10553268.
DOI: 10.1371/journal.pone.0292521.
The shared microbiome in mud crab () of Sanmen Bay, China: core gut microbiome.
Jiang X, Niu M, Qin K, Hu Y, Li Y, Che C
Front Microbiol. 2023; 14:1243334.
PMID: 37727291
PMC: 10505715.
DOI: 10.3389/fmicb.2023.1243334.
Gut check: Unveiling the influence of acute exercise on the gut microbiota.
Grosicki G, Langan S, Bagley J, Galpin A, Garner D, Hampton-Marcell J
Exp Physiol. 2023; 108(12):1466-1480.
PMID: 37702557
PMC: 10988526.
DOI: 10.1113/EP091446.
Effects of a Very-Low-Calorie Ketogenic Diet on the Fecal and Urinary Volatilome in an Obese Patient Cohort: A Preliminary Investigation.
Celano G, Calabrese F, Riezzo G, DAttoma B, Ignazzi A, Di Chito M
Nutrients. 2023; 15(17).
PMID: 37686784
PMC: 10490432.
DOI: 10.3390/nu15173752.
Bergamot Polyphenolic Extract Combined with Albedo and Pulp Fibres Counteracts Changes in Gut Microbiota Associated with High-Fat Diet: Implications for Lipoprotein Size Re-Arrangement.
Mollace R, Macri R, Nicita M, Musolino V, Gliozzi M, Carresi C
Int J Mol Sci. 2023; 24(16).
PMID: 37629146
PMC: 10454550.
DOI: 10.3390/ijms241612967.
Emerging Paradigms in Inflammatory Disease Management: Exploring Bioactive Compounds and the Gut Microbiota.
Benameur T, Porro C, Twfieg M, Benameur N, Panaro M, Filannino F
Brain Sci. 2023; 13(8).
PMID: 37626582
PMC: 10452544.
DOI: 10.3390/brainsci13081226.